收费全文 | 75431篇 |
免费 | 5484篇 |
国内免费 | 368篇 |
耳鼻咽喉 | 727篇 |
儿科学 | 1966篇 |
妇产科学 | 1809篇 |
基础医学 | 9232篇 |
口腔科学 | 1732篇 |
临床医学 | 7434篇 |
内科学 | 17225篇 |
皮肤病学 | 1008篇 |
神经病学 | 6183篇 |
特种医学 | 2359篇 |
外国民族医学 | 2篇 |
外科学 | 11275篇 |
综合类 | 1231篇 |
现状与发展 | 1篇 |
一般理论 | 108篇 |
预防医学 | 6657篇 |
眼科学 | 2069篇 |
药学 | 5320篇 |
中国医学 | 195篇 |
肿瘤学 | 4750篇 |
2023年 | 333篇 |
2022年 | 453篇 |
2021年 | 1401篇 |
2020年 | 857篇 |
2019年 | 1252篇 |
2018年 | 1650篇 |
2017年 | 1139篇 |
2016年 | 1221篇 |
2015年 | 1424篇 |
2014年 | 2137篇 |
2013年 | 3339篇 |
2012年 | 4556篇 |
2011年 | 5017篇 |
2010年 | 2860篇 |
2009年 | 2604篇 |
2008年 | 4801篇 |
2007年 | 5069篇 |
2006年 | 4823篇 |
2005年 | 4938篇 |
2004年 | 4633篇 |
2003年 | 4244篇 |
2002年 | 4137篇 |
2001年 | 1011篇 |
2000年 | 982篇 |
1999年 | 980篇 |
1998年 | 844篇 |
1997年 | 670篇 |
1996年 | 545篇 |
1995年 | 545篇 |
1994年 | 527篇 |
1993年 | 483篇 |
1992年 | 629篇 |
1991年 | 588篇 |
1990年 | 479篇 |
1989年 | 506篇 |
1988年 | 442篇 |
1987年 | 413篇 |
1986年 | 399篇 |
1985年 | 454篇 |
1984年 | 452篇 |
1983年 | 407篇 |
1982年 | 549篇 |
1981年 | 469篇 |
1980年 | 497篇 |
1979年 | 327篇 |
1978年 | 349篇 |
1977年 | 345篇 |
1976年 | 287篇 |
1975年 | 300篇 |
1974年 | 262篇 |
Objective
The aim of the study was to estimate the effect of the state-based reinsurance programs through the section 1332 State Innovation Waivers on health insurance marketplace premiums and insurer participation.Data Source
2015 to 2022 Robert Wood Johnson Foundation Health Insurance Exchange Compare Datasets.Study Design
An event study difference-in-differences (DD) model separately for each year of implementation and a synthetic control method (SCM) are used to estimate year-by-year effects following program implementation.Data Collection/Extraction Methods
Not applicable.Principal Findings
Reinsurance programs were associated with a decline in premiums in the first year of implementation by 10%–13%, 5%–19%, and 11%–17% for bronze, silver, and gold plans (p < 0.05). There is a trend of sustained declines especially for states that implemented their programs in 2019 and 2020. The SCM analyses suggest some effect heterogeneity across states but also premium declines across most states. There is no evidence that reinsurance programs affected insurer participation.Conclusion
State-based reinsurance programs have the potential to improve the affordability of health insurance coverage. However, reinsurance programs do not appear to have had an effect on insurer participation, highlighting the need for policy makers to consider complementary strategies to encourage insurer participation. 相似文献Areas covered: This review includes a view of the clinical classification and risk assessment in children suffering from HL. The chemotherapy more commonly employed is revisited. The use of PET/CT to evaluate the disease in order to guide therapy is analyzed. New options of chemotherapy and emerging immunotherapy are also included.
Expert opinion: In order to make the right treatment choice, a proper initial assessment of risk is mandatory. The choice of therapy in these kinds of patients must be done according to the experience of the team, and also, the cost and logistics related to the eligible scheme are very important. If possible, efforts must be made to include PET/CT in guiding therapy and avoiding overtreatment and long-term adverse effects in children. New options in immunotherapy are emerging and must be considered with caution in selected patients. 相似文献